ClinicalTrials.gg
Drug

Cenobamate clinical trials

Also written YKP3089 and Xcopri.

studies test it
18
open now
3
in phase 3
6
first study started
2007

How each study uses Cenobamate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Cenobamate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Nov 2019 · XCOPRI · NDA 212839 (FDA, Drugs@FDA)
European Union
26 Mar 2021 · Ontozry · EMEA/H/C/005377 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Cenobamate
12

Brand

Xcopri
2

Development codes

YKP3089
8

Studies by the year they started

18 studies that test it; most in 2022 (4)

Studies that test Cenobamate, by start year
YearStudies
20071
20111
20131
20161
20172
20181
20191
20201
20213
20224
20241
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
6
Phase 2
4
Phase 3
6
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 1

SK Life Science, Inc. (15) · Ono Pharmaceutical Co. Ltd (2) · Brigham and Women's Hospital (1)

Often tested with

Tested in the same studies.

Midazolam (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test Cenobamate, phase 3 first.

Studies

Open first, then newest update. How each study uses Cenobamate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Codes

What other systems call Cenobamate · ClinicalTrials.gg INT001213

  • MeSH (NLM) C000654784CenobamateConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) P85X70RZWSCENOBAMATEConfirmed FDA, NLM, Wikidata
  • RxNorm 2265690One source FDA
  • Wikidata Q27286352cenobamateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C174837CenobamateOne source FDA
  • DrugBank DB06119One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.